Susan Eshleman
Susan Eshleman
Professor of Pathology, Johns Hopkins University School of Medicine üzerinde doğrulanmış e-posta adresine sahip
Alıntı yapanlar
Alıntı yapanlar
Prevention of HIV-1 infection with early antiretroviral therapy
MS Cohen, YQ Chen, M McCauley, T Gamble, MC Hosseinipour, ...
New England journal of medicine 365 (6), 493-505, 2011
Antiretroviral therapy for the prevention of HIV-1 transmission
MS Cohen, YQ Chen, M McCauley, T Gamble, MC Hosseinipour, ...
New England Journal of Medicine 375 (9), 830-839, 2016
Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)
SH Eshleman, M Mracna, LA Guay, M Deseyve, S Cunningham, ...
Aids 15 (15), 1951-1957, 2001
Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial
B Grinsztejn, MC Hosseinipour, HJ Ribaudo, S Swindells, J Eron, ...
The Lancet infectious diseases 14 (4), 281-290, 2014
The amino acid at the X position of an Asn-X-Ser sequon is an important determinant of N-linked core-glycosylation efficiency
SH Shakin-Eshleman, SL Spitalnik, L Kasturi
Journal of Biological Chemistry 271 (11), 6363-6366, 1996
The amino acid following an asn-X-Ser/Thr sequon is an important determinant of N-linked core glycosylation efficiency
JL Mellquist, L Kasturi, SL Spitalnik, SH Shakin-Eshleman
Biochemistry 37 (19), 6833-6837, 1998
Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission
JB Jackson, G Becker-Pergola, LA Guay, P Musoke, M Mracna, ...
Aids 14 (11), F111-F115, 2000
Antiretroviral treatment for children with peripartum nevirapine exposure
P Palumbo, JC Lindsey, MD Hughes, MF Cotton, R Bobat, T Meyers, ...
New England Journal of Medicine 363 (16), 1510-1520, 2010
Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient-and sequence-level meta-analysis
SY Rhee, JL Blanco, MR Jordan, J Taylor, P Lemey, V Varghese, ...
PLoS medicine 12 (4), e1001810, 2015
Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the …
T Flys, DV Nissley, CW Claasen, D Jones, C Shi, LA Guay, P Musoke, ...
The Journal of infectious diseases 192 (1), 24-29, 2005
Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women
KH Mayer, LA Maslankowski, F Gai, WM El-Sadr, J Justman, A Kwiecien, ...
Aids 20 (4), 543-551, 2006
Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP
SH Eshleman, DR Hoover, S Chen, SE Hudelson, LA Guay, A Mwatha, ...
The Journal of infectious diseases 192 (1), 30-36, 2005
Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children
A Violari, JC Lindsey, MD Hughes, HA Mujuru, L Barlow-Mosha, ...
New England Journal of Medicine 366 (25), 2380-2389, 2012
Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations
W Huang, SH Eshleman, J Toma, S Fransen, E Stawiski, EE Paxinos, ...
Journal of virology 81 (15), 7885-7893, 2007
The hydroxy amino acid in an Asn-X-Ser/Thr sequon can influence N-linked core glycosylation efficiency and the level of expression of a cell surface glycoprotein
L Kasturi, JR Eshleman, WH Wunner, SH Shakin-Eshleman
Journal of Biological Chemistry 270 (24), 14756-14761, 1995
Correlates of HIV acquisition in a cohort of Black men who have sex with men in the United States: HIV prevention trials network (HPTN) 061
BA Koblin, KH Mayer, SH Eshleman, L Wang, S Mannheimer, C Del Rio, ...
PloS one 8 (7), e70413, 2013
Regulation of N-linked core glycosylation: use of a site-directed mutagenesis approach to identify Asn-Xaa-Ser/Thr sequons that are poor oligosaccharide acceptors
L Kasturi, C Hegang, SH Shakin-Eshleman
Biochemical Journal 323 (2), 415-419, 1997
The effect of a conditional cash transfer on HIV incidence in young women in rural South Africa (HPTN 068): a phase 3, randomised controlled trial
A Pettifor, C MacPhail, JP Hughes, A Selin, J Wang, FX Gómez-Olivé, ...
The Lancet Global Health 4 (12), e978-e988, 2016
LigAmp for sensitive detection of single-nucleotide differences
C Shi, SH Eshleman, D Jones, N Fukushima, L Hua, AR Parker, CJ Yeo, ...
Nature Methods 1 (2), 141-147, 2004
Antiretroviral therapies in women after single-dose nevirapine exposure
S Lockman, MD Hughes, J McIntyre, Y Zheng, T Chipato, F Conradie, ...
New England Journal of Medicine 363 (16), 1499-1509, 2010
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20